Lv4
468 积分 2023-04-11 加入
GLP-1 receptor agonist fails to halt Alzheimer’s disease
1个月前
已完结
Anti-CD20 monoclonal antibodies in multiple sclerosis: Rethinking the current treatment strategy
1个月前
已完结
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial
1个月前
已完结
Here’s why China’s science and innovation model is thriving
4个月前
已完结
Confirmatory population pharmacokinetic analysis for bapineuzumab phase 3 studies in patients with mild to moderate Alzheimer's disease
5个月前
已完结
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
6个月前
已完结
Impact of Pre-analytical Factors on Fluid Biomarker Measurements in Alzheimer Disease
6个月前
已完结
The genetic architecture of Parkinson's disease
6个月前
已完结
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies
6个月前
已完结
Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer’s Disease (P11-9.013)
7个月前
已完结
皖公网安备34019202002308
